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A B S T R A C T
Toxoplasma gondii is the causative pathogen for Toxoplasmosis. Bumped kinase inhibitor 1NM-PP1 in-
hibits the growth of T. gondii by targeting TgCDPK1. However, we recently reported that resistance to 1NM-
PP1 can be acquired via amutation in T. gondiimitogen-activated protein kinase like 1 (TgMAPKL-1). Further
characterization of how this TgMAPKL-1 mutation restores the inhibitory effect of 1NM-PP1 would shed
further light on the function of TgMAPKL-1 in the parasite life cycle. Therefore, we made parasite clones
with TgMAPKL-1 mutated at the gatekeeper residue Ser 191, which is critical for 1NM-PP1 susceptibil-
ity. Host cell lysis of RH/ku80-/HA-TgMAPKL-1S191A was completely inhibited at 250 nM 1NM-PP1, whereas
that of RH/ku80-/HA-TgMAPKL-1S191Y was not. By comparing 1NM-PP1-sensitive (RH/ku80-/HA-TgMAPKL-
1S191A) and -resistant (RH/ku80-/HA-TgMAPKL-1S191Y) clones, we observed that inhibition of TgMAPKL-1
blocked cell cycle progression after DNA duplication. Morphological analysis revealed that TgMAPKL-1
inhibition caused enlarged parasite cells with many daughter cell scaffolds and imcomplete cytokinesis.
We conclude that the mutation in TgMAPKL-1 restored the cell cycle-arresting effect of 1NM-PP1 on T.
gondii endodyogeny. Given that endodyogeny is the primary mechanism of cell division for both the
tachyzoite and bradyzoite stages of this parasite, TgMAPKL-1 may be a promising target for drug devel-
opment. Exploration of the signals that regulate TgMAPKL-1 will provide further insights into the unique
mode of T. gondii cell division.
© 2014 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Toxoplasma gondii is the causative pathogen for Toxoplasmosis.
It is a member of the Apicomplexans, which include several im-
portant pathogens, such as Plasmodium, Cryptosporidium, and
Neospora. Without cell division, parasites cannot increase the par-
asite burden and cannot effectively disseminate throughout the host.
Therefore, the cell division of parasites is essential to their life cycle.
Protozoa in the Apicomplexa exhibit various types of cell division
(Striepen et al., 2007). Toxoplasma and Neospora replicate via the
two cell division process in the asexual stage, whereas Plasmo-
dium species replicate by merogony (Arnot et al., 2011) in the blood
stage. How parasites select these cell division types in each infec-
tion stage remains largely unknown.
The mitogen-activated protein kinase (MAPK) family functions
in cell signaling to regulate cell division, cell differentiation, and stress
responses in eukaryotic cells (Zhang and Liu, 2002). Genome anal-
ysis suggests that there are three MAPKs in the apicomplexan
genome (Lacey et al., 2007). Api-MAPK2 and Api-MAPK3 are con-
served among apicomplexans; however, Api-MAPK1 shares no
homolog among Plasmodium species (Lacey et al., 2007). T. gondii
encodes a single Api-MAPK1, T. gondii mitogen-activated protein
kinase like 1 (TgMAPKL1) (TGME49_312570). Studies by Dr. Michael
White group referred to TGME49_312570 as TgMAPKL1 and found
that its similarity to mammalian MAPK is very low, being limited
to the protein kinase domain. We also studied TGME49_312570 and,
to avoid confusion, we changed our nomenclature of TgMAPK1 to
TgMAPKL1 in agreement with the White group (personal
communication).
We recently showed that TgMAPKL-1 appears to function in cell
division (Sugi et al., 2013). Brown et al. also demonstrated that the
protein kinase inhibitor SB505124, which directly targets TgMAPKL-
1, arrests parasite cell division (Brown et al., 2014). Brumlik et al.
further reported that parasites that expresses antisense RNA
for TgMAPKL-1 have a slow growth rate and altered host cell
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signaling (Brumlik et al., 2013). Thus, inhibition of TgMAPKL-1 leads
to parasite growth arrest, suggesting that TgMAPKL-1 has either a
direct or indirect role in parasite replication. Although TgMAPKL-1
seems to function in parasite growth, the predicted genome se-
quence of T. gondii suggests that it lacks MAPKK andMAPKKK, which
are upstream protein kinases for theMAPKs (Miranda-Saavedra et al.,
2012).
Bumped kinase inhibitors (BKIs) represent a promising drug lead
because they have little effect on mammalian protein kinases (Ojo
et al., 2014a) but appear to be a potent inhibitors of parasite growth
in vitro (Lourido et al., 2010; Murphy et al., 2010; Ojo et al., 2010;
Sugi et al., 2010) and in vivo (Doggett et al., 2014; Lourido et al.,
2013; Ojo et al., 2014b; Sugi et al., 2011). The primary targets of
the BKIs are CDPK1s that carry a small gatekeeper residue, which
makes the protein kinase sensitive to the BKIs. However, we re-
cently showed that TgMAPKL-1 is the secondary target of the BKIs
and that mutation of TgMAPKL-1 provides parasites with resis-
tance to BKIs (Sugi et al., 2013). Ojo et al., (2014b) reported that
BKI treatment of Neospora caninum inhibited the growth of the par-
asite in host cells – an effect that could not be explained as the result
of CDPK1 inhibition because CDPK1 reportedly works in invasion
and egress (Lourido et al., 2010; Sugi et al., 2010). Therefore, it is
important to investigate how BKIs inhibit parasites by targeting the
secondary target TgMAPKL-1. The investigation of themode of action
of bumped kinase inhibitor will help to reveal the atypical MAPK
signaling pathway involved in the parasite life cycle.
In the present report, we employed chemical genetics to inhibit
TgMAPKL-1 in an inducible manner. We used the bumped kinase
inhibitor 1NM-PP1 and parasites in which the gatekeeper residue
had been genetically mutated such that their susceptibility to this
BKI was altered (Bishop et al., 2000). Similar chemical-genetics ap-
proaches were previously used to analyze other protein kinases in
Toxoplasma (Donald et al., 2006; Lourido et al., 2010; Sugi et al., 2010)
and Plasmodium (Ojo et al., 2014a). By using a parasite bearing
TgMAPKL-1 with a small gatekeeper amino acid (BKI-susceptible)
and a parasite bearing TgMAPKL-1 with a large gatekeeper amino
acid (BKI-resistant), we could observe the effect of TgMAPKL-1 in-
hibition on parasite cell cycle progression. Here, we provide the ﬁrst
evidence that BKI affects parasite cell cycle progression by target-
ing TgMAPKL-1.
2. Materials and methods
2.1. Chemical reagents and antibodies
The following antibodies were used forWestern blotting and im-
munoﬂuorescence staining: an α-HA epitope tag rat monoclonal
antibody (Roche, Basel, Switzerland), α-TgIMC3 rat antisera
(Anderson-White et al., 2011), and an α-TgGAP45 rabbit polyclonal
antibody (Plattner et al., 2008). 1NM-PP1 (Merck KGaA,
Darmstadt, Germany) was dissolved in DMSO; ammonium
pyrrolidinedithiocarbamate (PDTC), RNase A, and propidium iodide
(Sigma-Aldrich, St. Louis, USA) were dissolved in distilled water.
2.2. Plasmids
To knock-in the gatekeeper mutated TgMAPKL-1 sequence in the
native TgMAPKL-1 locus on chromosome XI, we produced a con-
struct containing the 5’UTR from TgMAPKL-1, the HXGPRT selectable
marker cassette, and the TgMAPKL-1 cDNA sequence fused with an
N-terminal HA-epitope tag under the control of the GRA1 promot-
er sequence (Fig. 1A). Knock-in constructs for replacing the wild-
type TgMAPKL-1 sequence in the chromosomewith the gatekeeper-
substituted TgMAPKL-1 expression cassette were made as follows:
the HA-tag was ampliﬁed with primers HA_F and HA_R (Table 1)
from pCMV-HA (Takara, Shiga, Japan) and inserted into the EcoT22I
and EcoRI sites of pTgMAPK1-WT (Sugi et al., 2013). The resultant
plasmid was designated as pHA-TgMAPKL-1, which encodes the
TgMAPKL-1 expression cassette fused to the N-terminal HA-
epitope. For the knock-in by homologous recombination, the 5’UTR
of TgMAPKL-1 was ampliﬁed with the primers 5’UTR_F and 5’UTR_R
(Table 1) from the genomic DNA of RH/ku80-/hxgprt- and in-
serted into the HindIII site of pHA-TgMAPKL-1 by using the InFusion
cloning system (Takara). The resultant construct was designated as
pKnock-In-HA-TgMAPK1. To substitute the gatekeeper residue,
pKnock-In-HA-TgMAPK1 was PCR ampliﬁed with the primers
F_GK_Ala and R_GK_35, or F_GK_Tyr and R_GK_35 (Table 1). The
PCR fragments were ligated by using the InFusion cloning system.
2.3. Host cell culture
Human foreskin ﬁbroblast (HFF) cells were maintained in the
Dulbecco’s modiﬁed Eagle medium (DMEM) (Life Technologies)
supplemented with 25 mM HEPES, 50 U/ml penicillin, 50 μg/ml
streptomycin, and 10% fetal calf serum (FCS). Vero cells were main-
tained in the DMEM (Nissui Pharmaceutical, Tokyo, Japan)
supplemented with 50 U/ml penicillin, 50 μg/ml streptomycin, and
5% FCS. When the parasites were inoculated, DMEM (Nissui Phar-
maceutical) with 1% FCS was used.
2.4. Transgenic parasites
The parasite strain RH/ku80-/hxgprt- (Huynh and Carruthers,
2009) (ATCC: PRA319) was used as the parental strain of the trans-
genic parasites throughout this study. Parasites were maintained
and serially passaged to new host Vero cells as described else-
where (Roos et al., 1994). For transfection, plasmids were linearized
with HpaI and BsiWI. Then, 2.5 μg of linearized DNA was intro-
duced into 106 parasites by using Nucleofection with Nucleofector
II (Lonza, Basel, Switzerland) as described elsewhere (Sugi et al.,
2013). After selection with 25 μg/mL mycophenolic acid and 25 μg/
mL xanthine, parasites were cloned by limiting dilution, and the
resultant clones were subjected to PCR and PCR-RFLP analysis to
screen for clones with the replaced chromosome.
2.5. Host cell monolayer disruption assay
Host Vero cells were seeded in 96-well plates at a density of 104/
well and incubated for 24 h before parasite inoculation. Parasites
were ﬁlter-puriﬁed, counted, and inoculated at a density of 3 × 103/
well following incubation with the test concentration of 1NM-PP1
at room temperature for 10 min. Cells were incubated for 5 days
with medium changes every 2 days. After this incubation, the in-
fected host cells were ﬁxedwithmethanol, stainedwith crystal violet,
and then measured at OD600. Average values from non-treated and
mock-infected (control) wells were estimated to be 100%.
2.6. Cell cycle analysis
Cell cycle synchronization was performed by use of PDTC treat-
ment as described elsewhere (Conde de Felipe et al., 2008). Brieﬂy,
parasites were inoculated into Vero cells at a multiple of infection
1.0 and incubated for 12 h before PDTC treatment. Infected cells were
then treated with 80 μM PDTC for 8 h and then washed three times
at 37 °C with warm medium to wash out the PDTC. After the
washout, mediumwith or without 250 nM 1NM-PP1was added and
incubated extensively for 7 hours. Puriﬁed samples were pre-
pared for ﬂow cytometric analysis as described elsewhere (Conde
de Felipe et al., 2008). Brieﬂy, infected cells were washed with ice-
cold phosphate buffered saline (PBS) three times to remove the
extracellular parasites and were then harvested with scrapers. Host
cells were ruptured by serial passage through a 25G needle three
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times. Parasites were ﬁlter-puriﬁed with a φ5-μm pore ﬁlter unit
(Millipore, Billerica, USA), and then centrifuged at 2,000 × g for 5min
at 4 °C. To ﬁx and permeabilize the parasites, the pellets were re-
suspended in 300 μl of ice-cold 2% FCS PBS to which 700 μl of ice-
cold ethanol was added drop-wisewith vigorous pipetting; theywere
then incubated at –30 °C for more than 1 day. Fixed cells were then
washed once with 2% FCS PBS and the pellet was resuspended in
PI solution (40 μg/ml propidium iodide, 360 μg/ml RNase A, and 2%
bovine serum albumin (BSA) in PBS) and ﬁltered with a φ5-μm pore
ﬁlter just after resuspension. The ﬁltered parasites in PI solutionwere
incubated at 37 °C for 30min and then used for ﬂow cytometric anal-
ysis with Epics XL (Beckman Coulter).
2.7. Immunoﬂuorescence staining
Parasites were inoculated into host HFF cells cultured on
cover slips and incubated for 24 or 48 h to observe the effect of
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Fig. 1. Double homologous recombination of the native TgMAPKL-1 locus in the chromosome to substitute the gatekeeper residue. (A) Schematic depiction of the knock-in
construct. The red arrows show the locations of primers 1 and 2 for the PCR analysis. The blue arrows show the locations of primers 3 and 4 for the PCR-RFLP analysis. The
graph shows chromosome XI around the TgMAPKL-1 locus. The blue boxes show the coding sequence of TgMAPKL-1. (B) PCR analysis of the recombinant chromosomal
sequence in the knock-in clones. The 3’UTR and the coding sequence of TgMAPKL-1 were ampliﬁed with primer sets 1 and 2. The 5’UTR and the coding sequence of TgMAPKL-1
were ampliﬁed with primer sets 3 and 4. For the PCR-RFLP analysis, the PCR fragments ampliﬁed with primers 3 and 4 were digested with the ClaI restriction enzyme.
Parent indicates the RH/ku80-/hxgprt- strain. (C) An anti-HA tag antibody (left panel) or an anti-TgALD1 antibody (right) was used to detect protein from the total lysate of
each parasite clone. Puriﬁed parasites were lysed in 1 × SDS-PAGE sample buffer and 106 parasites/lane were loaded onto the gel. Molecular masses are shown to the right
of each panel. (D) Tachyzoites of each clone were cultured in HFF cells on cover slips. Green shows the HA-tagged TgMAPKL-1 detected with the anti-HA antibody and blue
shows the nuclei. To observe the parasite shape, TgGAP45 was stained and is shown in red. Scale bars = 10 μm.
Table 1
Primers used in the present study.
ID Sequence (5’- > 3’)
HA_F GAAATGCATACCATGTACCCATACGATGT
HA_R TGTGAATTCGCGTAATCTGGAACATCGT
5’UTR_F CGGTATCGATAAGCTCAAGAAAAGCAACGAGAGAT
5’UTR_R CGTGCTGATCAAGCTATGGTGGCGAAGAGTTGAG
R_GK_35 GACGAGGTAAATGTCCTCGAAATCTGGAGTCAG
F_GK_Ala GACATTTACCTCGTCgcTGACCTGATGGACAC
F_GK_Tyr GACATTTACCTCGTCTaTGACCTGATGGACAC
PCR_screen_1 TGAGTCAGAGCACGAGTGCCGGAGGCAGCCAAGCT
PCR_screen_2 CCGACAGAAGTCAAAAGGGAATGAGATGCCAGGTAT
PCR_screen_3 TATTTCTTCTGACCGCACGACCTTTCGCAGTTCAG
PCR_screen_4 AGCTGTTGCTGGCCATGCTGCAGCTGTTGTTGCCT
Boldface type shows the restriction enzyme sites. Underlined sequences are ho-
mologous sequences for the In-Fusion cloning system. Lower case italicized characters
represent the mutated sequences.
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treatment with 250 nM 1NM-PP1. 1NM-PP1 treatments were started
from 2 h post-parasite inoculation. To observe the normal tachyzoite,
inoculated parasites were incubated for 24 h. Staining was per-
formed as described elsewhere (Tomita et al., 2013); brieﬂy, cells
were ﬁxed with 4% paraformaldehyde for 20 min, and were then
permeabilized with 0.2 M glycine, 0.2% TrintonX-100 in PBS for
15min at room temperature and blockedwith 2% BSA in 0.1% Tween-
20 PBS (blocking buffer) for 30 min. The primary antibody reaction
was performed in blocking buffer at a dilution of 1:500. After the
primary antibody reaction, the cells were washed three times with
0.1% Tween-20 PBS and then incubated with secondary antibod-
ies conjugated to ALEXA (Life Technologies) and DAPI (Life
Technologies) in blocking buffer at dilutions of 1:1000. Antibody re-
actions were performed overnight at 4 °C. After the secondary
antibody reaction, the cells were washed ﬁve times with PBS and
mounted with ﬂuorescence mounting medium (DAKO, Glostrup,
Denmark). Stained cells were observed by using a confocal laser scan-
ning microscope TCS SP5 (Leica Microsystems, Wetzlar, Germany).
3. Results
3.1. Construction of gatekeeper amino acid-substituted TgMAPKL-1
by use of double homologous recombination
First, we introduced the mutation into TgMAPKL-1 in the par-
asite chromosome by using double homologous recombination. The
knock-in construct (Fig. 1A) contained the 5’UTR from TgMAPKL-
1, a HXGPRT selectable marker cassette, and the coding sequence
of TgMAPKL-1 with or without the mutation in the gatekeeper
residue Ser 191 fused to an N-terminal HA-epitope tag and driven
by the GRA1 promoter. Linearized construct was introduced into the
RH/ku80-/hxgprt- parental strain to obtain recombinant clones ef-
fectively. We established clones with the wild-type TgMAPKL-1
sequence (RH/HA-WT) and the mutated TgMAPKL-1 sequence (RH/
HA-S191A and RH/HA-S191Y). Double homologous recombination
by the knock-in construct was conﬁrmed by PCR and a PCR-RFLP
assay. Primer pairs 1 and 2 ampliﬁed about 14 kbp of DNA from pa-
rental RH/ku80-/hxgprt-, whereas about 9 kbp of DNAwas ampliﬁed
from the recombinant clones (Fig. 1B). Fragments ampliﬁed with
primer pairs 3 and 4 and digested with the ClaI restriction enzyme
showed a single band for the parental RH/ku80-/hxgprt-, whereas
two bands were detected after ClaI digestion for the knock-in clones
(Fig. 1B).
Expression of the HA-tagged TgMAPKL-1 was conﬁrmed with
Western blotting and immunoﬂuorescence staining. An anti-HA-
epitope tag antibody detected a single bandwith amolecular weight
of approximately 150 kDa from the protein lysate of RH/HA-WT, RH/
HA-S191A, and RH/HA-S191Y, whereas no speciﬁc bandwas detected
from the parental RH/ku80-/hxgprt- (Fig. 1C). HA-TgMAPKL-1 was
detected in the parasite cytosol of RH/HA-WT, RH/HA-S191A and
RH/HA-S191Y, but no signal was detected from RH/ku80-/hxgprt-
(Fig. 1D).
3.2. Gatekeeper amino acid substitution of TgMAPKL-1 subverts the
1NM-PP1 effect on parasite growth
Next, we determined the inﬂuence of substituting the gate-
keeper residue fromwild-type Ser 191 to Ala (RH/HA-S191A) or Tyr
(RH/HA-S191Y) on parasite susceptibility to the bumped kinase in-
hibitor 1NM-PP1. We used a host monolayer disruption assay to
evaluate the 1NM-PP1-induced inhibition of parasite growth. Treat-
ment with 250 nM 1NM-PP1 inhibited RH/HA-S191A and parental
RH/ku80-/hxgprt- parasite growth and host cells were not lysed
(Fig. 2), whereas host cells were lysed when RH/HA-WT and RH/
HA-S191Y were treated with 250 nM 1NM-PP1 (Fig. 2). RH/HA-
WT grewmore slowly than the other strain in the absence of 1NM-
PP1 (Fig. 2).
3.3. Inhibition of TgMAPKL-1 by 1NM-PP1 causes cell cycle arrest
Next, by comparing the 1NM-PP1-sensitive RH/HA-S191A and
the 1NM-PP1-resistant RH/HA-S191Y following 1NM-PP1 treat-
ment, we analyzed the effect of TgMAPKL-1 on cell cycle progression.
We used ﬂow cytometry to measure the DNA contents in the single
parasite cells to analyze the cell cycle populations of G1 (1N) and
S, M/C ( over 1N). All strains, parental RH/ku80-/hxgprt-, RH/HA-
WT, RH/HA-S191A, and RH/HA-S191Y, were synchronized by using
PDTC treatment and showed G1 accumulated peaks in the DNA
content analysis by ﬂow cytometry (Fig. 4A and 4B upper panels).
After PDTC release, all of the strains progressed to the next G1 cycle
during a 7-h incubation in the absence of 1NM-PP1 (Fig. 3A and 3B,
middle panels). However, in the presence of 250 nM 1NM-PP1 during
the 7-h incubation after PDTC release, parental RH/ku80-/hxgprt-
and RH/HA-S191A showed accumulation of parasites with 2N DNA
content (M/C), whereas RH-WT and RH/HA-S191Y showed G1 peaks
(Fig. 3B bottom panels). Accumulation of the over 1N peak in the
ﬂow cytometric analysis suggested that the parasite cell cycle did
not progress normally, such that the cell cycle was delayed or ar-
rested after DNA duplication.
3.4. Morphological analysis of cell cycle-arrested parasites
To ﬁnd out whether the cell cycle progression was arrested or
progression was merely slowed by the inhibition of TgMAPKL-1, we
examined themorphology of 1NM-PP1-treated parasites.We stained
TgGAP45 to observe the parasite inner membrane complex beneath
the single parasite cell cytoplasmic membrane. Parasite nuclei were
stained with DAPI to determine whether a single nucleus or mul-
tiple nuclei were located in individual parasite cells. When parasites
were treated with 250 nM 1NM-PP1 for 2 days, parental RH/ku80-/
hxgprt- and RH/HA-S191A grew abnormally, and enlarged cells were
observed in the parasitophorous vacuole (Fig. 4). In the enlarged
cells, TgGAP45 was distributed beneath the large cell membrane
and a protrusion from the large cell body was observed (Fig. 4).
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1NM-PP1-resistant RH/HA-WT and RH/HA-S191Y, however, showed
the normal tachyzoite shape after 250 nM 1NM-PP1 treatment
(Fig. 4). The expression of HA-TgMAPKL-1 was not diminished by
1NM-PP1 treatment; however, the expression of HA-TgMAPKL-
1S191A in the midportion of the enlarged cells was faint (Fig. 4 left
panels). RH/HA-WT grew normally in the tachyzoite form but un-
divided parasites were also observed in the parasitophorous vacuole
(Fig. 4). DNA staining revealed that the enlarged cells of RH/ku80-/
hxgprt- and RH/HA-S191A had dispersed nuclei (Fig. 4). These data
suggest that inhibition of TgMAPKL-1 led to incomplete cell divi-
sion, in addition to a possible delay in cell cycle progression, but
did not completely arrest DNA replication.
3.5. Inhibition of TgMAPKL-1 affects daughter cell formation
Next, we checked daughter cells formation in the cytokinesis-
defect parasites. To distinguish between the mother cell inner
membrane and the daughter cell scaffold, we used TgGAP45 as a
mother cell inner membrane complex marker (Gaskins et al., 2004)
and TgIMC3 as a daughter cell inner membrane complex marker.
When the parasites were incubated with the DMSO solvent control,
the dividing mother parasites stained with TgGAP45 contained two
daughter cells stained with TgIMC3 (Fig. 5A), suggesting that knock-
in of the HA-tagged TgMAPKL-1 did not alter the “endodyogeny-
type cell division”.
When we treated the infected cells with 250 nM 1NM-PP1, the
dividing mother cells of RH/HA-WT and RH/HA-S191Y contained
two daughter cells, which were similar to the non-treated group
(Fig. 5B). However, 1NM-PP1 treatment caused enlargedmother cells
in the parental RH/ku80-/hxgprt- and RH/HA-S191A clones. In these
enlarged cells, protrusions of the TgGAP45-positive inner mem-
brane complex and of the TgIMC3-positive daughter cell inner
membrane complex were observed (Fig. 5B).
Segregated nuclei were observed in the daughter cells of the en-
larged mother cells (Fig. 5B); at the same time, large nuclei which
were not enveloped by the daughter cell inner membrane complex
were also observed (Fig. 5B). Collectively, these data suggest that
TgMAPKL-1 inhibition caused a cytokinesis defect in the enlarged
parasite cells, but did not completely arrest nucleus duplication and
daughter cell formation in the cytokinesis-disrupted enlarged cells.
4. Discussion
In this report, we characterized the function of TgMAPKL-1 in
parasite growth by using a chemical genetics approach. When the
gatekeeper residue of TgMAPKL-1 is mutated, the inhibitory effect
of 1NM-PP1 drastically changes especially with respect to cell cycle
arrest after DNA duplication. 1NM-PP1-sensitive transgenic para-
sites containing TgMAPKL-1S191A produced many daughter cell
scaffolds within the enlarged maternal cells. This ﬁnding indicates
that the mutation in TgMAPKL-1 changed the cell division style of
the T. gondii tachyzoite, which usually divides in the endodyogeny
style.
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The previously reported phenotype of TgMAPKL-1 inhibition
causing slow parasite growth (Brumlik et al., 2013; Sugi et al., 2013)
is consistent with our ﬁndings in this study. The previous report by
Brumlik et al. showed that downregulation of TgMAPKL-1 causes
changes in host manipulation (Brumlik et al., 2013); however, our
HA-tagged TgMAPKL-1 localized in the parasite cytosol. There-
fore, the concept of TgMAPKL-1 directly manipulating host signals
remains to be conﬁrmed. We only tested the N-terminal HA-
tagged full-length mRNA isoform of TgMAPKL-1 because the HA-
TgMAPKL-1 successfully replaced the native TgMAPKL-1 locus,
suggesting that therewas no loss of function in the parasite. However,
the tagging and the mRNA splicing of the isoform might have af-
fected the localization of TgMAPKL-1. Overexpression of the wild-
type TgMAPKL-1 locus confers resistance to 1NM-PP1. Therefore,
the overexpression of TgMAPKL-1 itself must have an effect on re-
sistance. However, all of the overexpressed TgMAPKL-1 protein (i.e.,
WT, S191A, and S191Y) were expressed to the same level, accord-
ing to our Western blotting analysis. Nevertheless, we cannot rule
out the possibility that mutation of the TgMAPKL-1 gatekeeper
residue changes the kinase activity, which in turn could alter the
underlying BKI sensitivity of the parasites. TgMAPKL-1 variant ex-
pression conferred a different level of resistance to the parasites.
This resistance appeared to result from the TgMAPKL-1 function.
However to determine whether 1NM-PP1 directly targets TgMAPKL-
1, in vitro protein kinase assayswith TgMAPKL-1 should be performed
in future studies. We have tried to express the full-length form of
TgMAPKL-1, but so far we have been unsuccessful.
Notably, we observed that the nucleus was somewhat segregat-
ed in the enlarged cells, that daughter cell scaffold stained by TgIMC3
was constructed, but that the inner membrane complex stained by
TgGAP45was not divided. TgGAP45 is located reportedly in the inner
membrane complex of mature (or completely budded) cells (Gaskins
et al., 2004); therefore, our ﬁndings suggest that the normal func-
tion of TgMAPKL-1 is essential for the completion of budding. Recent
work by Brown et al. showed that the ALK4, 5, and 7 inhibitor
SB505124 inhibits TgMAPKL-1 directly (Brown et al., 2014). They
also found that the nucleus number in the parasite body was ab-
normal and that SB505124-treated parasites produced swollen cells
(Brown et al., 2014). Another study by Dr. Michael White’s group
using a temperature-sensitive allele also demonstrated that
TgMAPKL-1 is needed for the coordinated progression of cytoki-
nesis (personal communication).
Ojo et al. recently reported similar enlarged parasite cells in
Neospora caninum treated with the bumped kinase inhibitor 1294
(Ojo et al., 2014b). N. caninum treated with 1294 also showed seg-
regated nuclei, and large nuclei within the undivided cells were
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1, an anti-HA antibody was used (shown in green). To observe the inner membrane
complex underneath the parasite cell membrane, an anti-TgGAP45 antibody was used
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observed by use of TEM analysis (Ojo et al., 2014b). Ojo et al. did
not determine the speciﬁc target molecule responsible for the en-
largement, however they described the TgMAPKL-1 homolog in the
Neospora genome (NcMAPKL-1) (NCLIV_056080) (Ojo et al., 2014b)
as being of high similarity (72% positive amino acid by Blast anal-
ysis) (ToxoDB ver. 11.0). NcMAPKL-1 has a gatekeeper residue of Ser,
which is the same as that of T. gondii. Residues 162 Leu and 171
Ile of TgMAPKL-1, which are the mutation sites that inﬂuence BKI
susceptibility (Sugi et al., 2013), are conserved in NcMAPKL-1 (159
Leu and 168 Ile). Therefore, the bumped kinase inhibitor may target
MAPK1 and cause the enlarged parasite cells in both species. In the
present report, we obtained resistant parasites by substituting the
gatekeeper residue S191 of TgMAPKL-1. However, the mutation site
in the TgMAPKL-1 of the resistant parasites in the previous report
(Brown et al., 2014; Sugi et al., 2013) was located at L162 and I171.
It will be important to compare the level of resistant to the BKI
induced by the gatekeeper substitution to that induced by the pre-
viously found mutation to predict the occurrence of such BKI-
resistant mutations in parasites.
Abnormal undivided parasite cells and upregulation of bradyzoite-
speciﬁc gene expression following protein kinase inhibitor treatment
have been reported (Brown et al., 2014; Wei et al., 2002). We re-
cently showed that bumped kinase inhibitors increase bradyzoite-
speciﬁc BAG1 gene promoter activity by using reporter parasites (Sugi
et al., 2014). Bradyzoite-inducible stressors such as high pH and CO2
depletion cause a cell division defect, which results in the asyn-
chronous cell division of parasites in the parasitophorous vacuoles
(Dzierszinski et al., 2004). However, enlarged parasites, such as those
seenwith the 2-day TgMAPKL-1 inhibition, are not seen in the native
cyst. Therefore, future studies should examine whether inhibiting
TgMAPKL-1 leads to bradyzoite-inducing effects.
Even if TgMAPKL-1 plays a role in the regulation of the cell cycle,
the Toxoplasma genome lacks the typical upstream activator MAPKK
class protein kinases (Miranda-Saavedra et al., 2012). Other protein
kinases in T. gondii, TgNEK1 (Chen and Gubbels, 2013) and TgCDPK7
(Morlon-Guyot et al., 2014), reportedly play roles in mitosis, par-
ticularly in normal centrosome segregation. The enlarged parasite
cells in our study showed segregated nuclei, but some of the nuclei
seemed to be larger than the single nucleus of a normal tachyzoite.
Interestingly, activation of ApiMAPKs by NEK has been reported for
pfmap2 by pfnek1 in vitro (Dorin et al., 2001). Even if TgMAPKL-1
has no homolog in Plasmodium species, the activation mecha-
nisms of MAPKs might be common among the Apicomplexan
MAPKs. TgNEK1 and TgCDPK7 may work as upstream regulators of
TgMAPKL-1 instead of MAPKK, which is absent in T. gondii. The
budding defect in the enlarged cells is the same as that seen with
the MORN1 knockout parasite (Lorestani et al., 2010). Moreover,
Gubbels et al. reported on temperature-sensitive clones that have
a defect in late budding and cell division (Gubbels et al., 2008). A
better understanding of the relationship between TgMAPKL-1 and
these other reported proteins that are essential to cytokinesis will
help to reveal the cell cycle regulating signals. In order to discover
the signaling pathway through which TgMAPKL-1 participates in
cell cycle regulation, further quantitative analysis using other cell
cycle markers, such as TgMORN1 and centrosomes, will be needed
to determine the exact step(s) that involve TgMAPKL-1.
Our data suggest that TgMAPKL-1 is involved in the control of
normal cytokinesis following single DNA duplication in enlarged par-
asite cells. Hu et al. reported that some populations of T. gondii can
go through multiple daughter cell divisions rather than diploid cell
division spontaneously (Hu et al., 2004). Therefore, there may be
an adjustable signal for selecting the type of cell division. The char-
acterization of the upstream and downstream effectors of TgMAPKL-
1, as well as studies of how TgMAPKL-1 is regulated without a typical
upstream MAPKK, may provide insights into the mechanisms that
regulate the Toxoplasma cell cycle. Given that cell division is essen-
tial for the growth of parasites, our data suggest that TgMAPKL-1
is a promising drug target for the Toxoplasma parasite.
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